https://www.indianpharmapost.com/alkem-signs-license-agreement-with-takeda-to-commercialise-vonoprazan-in-india-161232024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/enzene-appoints-new-site-lead-of-biologics-manufacturing-161242024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-advances-ambition-to-improve-standards-of-care-in-multiple-cancer-types-161252024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-fenebrutinib-demonstrated-near-complete-suppression-of-disease-activity-and-disability-progression-161262024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/cupid-targets-rs-50-crore-topline-from-b2c-in-fy-2024-25-161272024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/steer-world-appoints-dhiraj-tiwari-as-cfo-161282024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/siegfried-opens-quality-control-lab-in-minden-161292024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-pharma-canada-announces-us-8-million-investment-in-egenesis-161302024-09-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-launches-mirabegron-er-tablets-in-us-161312024-09-04T00:00:00+05:30always0.9